Review: taking Allegra and Zantac together


Summary

Drug interactions are reported among people who take Allegra and Zantac together. This review analyzes the effectiveness and drug interactions between Allegra and Zantac. It is created by eHealthMe based on reports of 1,280 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Allegra and Zantac >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Allegra

Allegra has active ingredients of fexofenadine hydrochloride. It is often used in hypersensitivity. (latest outcomes from Allegra 25,605 users)

Zantac

Zantac has active ingredients of ranitidine hydrochloride. It is often used in indigestion. (latest outcomes from Zantac 35,120 users)

On Jul, 22, 2016

1,280 people who take Allegra, Zantac are studied.


Number of reports submitted per year:

Allegra and Zantac drug interactions.

Drug effectiveness over time:

Allegra:
  • < 1 month: 10.0% - (1 of 10 people)
  • 1 - 6 months: 0.0% - (0 of 11 people)
  • 6 - 12 months: 0.0% - (0 of 5 people)
  • 1 - 2 years: 50.0% - (2 of 4 people)
  • 2 - 5 years: 66.0% - (8 of 12 people)
  • 5 - 10 years: 14.0% - (1 of 7 people)
  • 10+ years: 50.0% - (1 of 2 people)
  • not specified: 0.0% - (0 of 0 people)
Zantac:
  • < 1 month: 21.0% - (3 of 14 people)
  • 1 - 6 months: 20.0% - (3 of 15 people)
  • 6 - 12 months: 12.0% - (1 of 8 people)
  • 1 - 2 years: 50.0% - (3 of 6 people)
  • 2 - 5 years: 18.0% - (2 of 11 people)
  • 5 - 10 years: 0.0% - (0 of 2 people)
  • 10+ years: 16.0% - (1 of 6 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Allegra:
  • female: 26.0% - (11 of 42 people)
  • male: 22.0% - (2 of 9 people)
Zantac:
  • female: 19.0% - (10 of 52 people)
  • male: 30.0% - (3 of 10 people)

Drug effectiveness by age:

Allegra:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 50.0% - (1 of 2 people)
  • 20-29: 20.0% - (1 of 5 people)
  • 30-39: 44.0% - (4 of 9 people)
  • 40-49: 15.0% - (2 of 13 people)
  • 50-59: 25.0% - (3 of 12 people)
  • 60+: 22.0% - (2 of 9 people)
Zantac:
  • 0-1: 0.0% - (0 of 1 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 50.0% - (1 of 2 people)
  • 20-29: 0.0% - (0 of 5 people)
  • 30-39: 20.0% - (2 of 10 people)
  • 40-49: 22.0% - (5 of 22 people)
  • 50-59: 25.0% - (3 of 12 people)
  • 60+: 22.0% - (2 of 9 people)

Most common drug interactions over time *:

< 1 month:
  • abdominal pain
  • hypokalaemia
  • liver carcinoma ruptured
  • aspartate aminotransferase increased
  • chest tightness
  • diaphoresis
  • flushing
  • headache
  • hypertension aggravated
  • muscle tightness
1 - 6 months:
  • seborrhoeic keratosis
  • acute myocardial infarction
  • asthma
  • nasal disorder
  • ventricular fibrillation
  • vertigo positional
  • abdominal pain
  • dizziness
  • cardiac arrest
  • drug exposure during pregnancy
6 - 12 months:
  • erythema multiforme
  • pulmonary embolism
  • anxiety
  • cognitive deterioration
  • confusion
  • drug exposure during pregnancy
  • injury
  • insomnia
  • pain
  • pregnancy
1 - 2 years:
  • hyperglycaemia
  • nausea
  • type 2 diabetes mellitus
  • vomiting
  • blepharal papilloma
  • blood creatinine increased
  • blood glucose
  • blood potassium decreased
  • brain injury
  • candidiasis
2 - 5 years:
  • dystonia
  • erythema multiforme
  • cardiac failure congestive
  • coronary artery disease
  • fracture
  • ischaemic cardiomyopathy
  • lower limb fracture
  • osteoporosis
  • renal failure chronic
  • rib fracture
5 - 10 years:
  • hippus
  • suicidal ideation
  • dystonia
  • paraesthesia
  • weakness
  • platelet count
  • chest pain
10+ years:
  • paraesthesia
  • weakness
  • painful respiration
  • urinary frequency
  • urination - bed wetting
not specified:
  • dyspnoea
  • anxiety
  • pain
  • fall
  • dizziness
  • chest pain
  • fatigue
  • back pain
  • diarrhoea
  • nausea

Most common drug interactions by gender *:

female:
  • anxiety
  • pain
  • fall
  • back pain
  • dyspnoea
  • dizziness
  • diarrhoea
  • chest pain
  • nausea
  • bone disorder
male:
  • chest pain
  • depression
  • dizziness
  • hypercholesterolaemia
  • hypoaesthesia
  • dyspnoea
  • fatigue
  • myalgia
  • cough
  • diarrhoea

Most common drug interactions by age *:

0-1:
  • blood glucose increased
  • blood potassium decreased
  • delirium
  • dementia
  • diabetic hyperosmolar coma
  • electrolyte imbalance
  • encephalopathy
  • hyperglycaemia
  • hyperlipidaemia
  • hypomagnesaemia
2-9:
  • aggression
  • agitation
  • arrhythmia
  • cough
  • dyspnoea
  • insomnia
  • sudden death
  • unresponsive to stimuli
  • vomiting
  • abdominal pain
10-19:
  • nausea
  • fatigue
  • abdominal distension
  • abdominal pain
  • brain death
  • brain herniation
  • cerebral ischaemia
  • cerebrovascular accident
  • cough
  • deep vein thrombosis
20-29:
  • pruritus
  • nausea
  • urticaria
  • dyspnoea
  • flushing
  • throat tightness
  • drug exposure during pregnancy
  • haemorrhage
  • nasal congestion
  • anticholinergic syndrome
30-39:
  • chest pain
  • anxiety
  • dyspnoea
  • pain
  • headache
  • injury
  • drug ineffective
  • urticaria
  • arthralgia
  • asthma
40-49:
  • abdominal pain
  • chest pain
  • dyspnoea
  • nausea
  • back pain
  • depression
  • fall
  • headache
  • pneumonia
  • pyrexia
50-59:
  • chest pain
  • dizziness
  • nausea
  • arthralgia
  • headache
  • pain
  • back pain
  • fall
  • vomiting
  • anxiety
60+:
  • anxiety
  • bone disorder
  • diarrhoea
  • fall
  • dyspnoea
  • myalgia
  • pain
  • cough
  • fatigue
  • spinal osteoarthritis

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Allegra and Zantac?

Can you answer these questions?

More questions for: Allegra, Zantac

You may be interested in these reviews

More reviews for: Allegra, Zantac

On eHealthMe, Allegra (fexofenadine hydrochloride) is often used to treat hypersensitivity. Zantac (ranitidine hydrochloride) is often used to treat indigestion. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.